Can we predict which patients will evolve to chronic kidney disease after nephrectomy for cortical renal tumors?
Age is an independent predictive factor of GFR loss for patients submitted to radical nephrectomy for cortical renal tumors.
Intravenous methotrexate can be safely administered concurrently with R-CHOP and is associated with a low risk of CNS recurrence in high-risk patients.